文献速递肥胖与代谢综合征糖尿病

肥胖与慢性肾脏病及动脉硬化的因果关联:孟德尔随机化研究

Causal Associations of Obesity With Chronic Kidney Disease and Arterial Stiffness: A Mendelian Randomization Study.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

结果显示BMI每增加1个标准差,慢性肾脏病风险OR为2.36(95%CI 1.11-5.00),动脉硬化风险OR为1.71(95%CI 1.22-2.39),提示肥胖对CKD和动脉硬化具有因果效应。

要点

  • BMI每升高1个标准差,CKD风险增加约2.36倍(OR 2.36,95%CI 1.11-5.00)。
  • BMI每升高1个标准差,动脉硬化风险增加约1.71倍(OR 1.71,95%CI 1.22-2.39)。
  • 肥胖对CKD和动脉硬化的因果关联提示体重管理对亚临床血管病变一级预防的重要性。

核心结论

  • 肥胖与慢性肾脏病及动脉硬化存在因果关联,体重管理对亚临床血管疾病的一级预防和控制具有重要意义。

研究设计与样本

  • CKD定义为估算肾小球滤过率低于60 mL/min/1.73 m2,动脉硬化定义为臂踝脉搏波传导速度大于1550 cm/s。

主要发现

  • 以遗传风险评分为工具变量,BMI每增加1个标准差,CKD的OR为2.36(95%CI 1.11-5.00),动脉硬化的OR为1.71(95%CI 1.22-2.39)。
  • 以14个单个SNV为工具变量行逆方差加权分析,BMI每增加1个标准差,CKD的OR为2.58(95%CI 1.39-4.79),动脉硬化的OR为1.87(95%CI 1.24-2.81)。
  • 肥胖与CKD的因果关联在欧洲人群两样本孟德尔随机化分析中得到验证。

关键数值与推荐

  • CKD定义:估算肾小球滤过率低于60 mL/min/1.73 m2。
  • 动脉硬化定义:臂踝脉搏波传导速度大于1550 cm/s。
  • 工具变量:14个东亚人群验证的BMI相关变异构建的遗传风险评分及14个单个SNV。

临床怎么用

  • 对肥胖患者应重视体重管理,以降低慢性肾脏病和动脉硬化的风险。
  • 在临床中可将BMI作为亚临床血管病变风险评估的参考指标之一。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Observational studies have been associated obesity with chronic kidney disease (CKD) and arterial stiffness, but the causality remains unclear. OBJECTIVE: We aimed to investigate the causality of obesity with CKD and arterial stiffness using mendelian randomization (MR) analysis. METHODS: We genotyped 14 body mass index (BMI)-associated variants validated in East Asians in 11 384 Chinese adults. A genetic risk score based on the 14 variants and the 14 individual single-nucleotide variations (SNVs, formerly single-nucleotide polymorphisms [SNPs]) were respectively used as instrumental variables (IVs). CKD was defined as estimated glomerular filtration rate less than 60 mL/min/1.73 m2. Arterial stiffness was defined as brachial-ankle pulse wave velocity greater than 1550 cm/s. RESULTS: Using the genetic risk score as the IV, we demonstrated causal relations of each 1-SD increment in BMI with CKD (odds ratio [OR]: 2.36; 95% CI, 1.11-5.00) and arterial stiffness (OR: 1.71; 95% CI, 1.22-2.39). Using the 14 SNVs individually as IVs, each 1-SD increment in BMI was casually associated with CKD (OR: 2.58; 95% CI, 1.39-4.79) and arterial stiffness (OR: 1.87; 95% CI, 1.24-2.81) in the inverse-variance weighted analysis, and MR-Egger regression revealed no evidence of horizontal pleiotropy (both P for intercept ≥ .34). The causality between obesity and CKD was validated in 2-sample MR analysis among Europeans (681 275 of Genetic Investigation of ANthropometric Traits and 133 413 of CKD Genetics). CONCLUSION: This study provided novel insights into the causality of obesity with CKD and arterial stiffness, highlighting the importance of weight management for primary prevention and control of subclinical vascular diseases.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Ye C, Kong L, Zhao Z, et al. Causal Associations of Obesity With Chronic Kidney Disease and Arterial Stiffness: A Mendelian Randomization Study. J Clin Endocrinol Metab. 2022. PMID: 34448477. doi:10.1210/clinem/dgab633

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。